This week in Orthopedics
Nov 19, 2026
Timing of platelet-rich plasma administration in arthroscopic rotator cuff repair: A systematic review and meta-analysis of randomised controlled trials.
Across 15 randomized trials, intraoperative platelet-rich plasma roughly cut rotator cuff retear risk by half, but pooled functional scores showed no consistent benefit over control.
Knee Surgery Sports Traumatology Arthroscopy · 2026 · PubMed
This week’s highlights
Read the weekly briefing
This AudioScholar briefing is generated by artificial intelligence from PubMed abstracts for healthcare professionals and is not medical advice.
This week: platelet-rich plasma at rotator cuff repair and retear rates, a national register on hip fracture surgery after hours, and a small trial adding marrow stimulation to meniscal repair.
Welcome to This Week in Orthopedics. We're covering 10 papers this week: 3 in depth, 4 in brief, 3 quick signals.
In Knee Surgery Sports Traumatology Arthroscopy, Pakmanee and colleagues report a two-centre, double-blind randomized trial of 50 adults aged 18 to 60 with isolated meniscal tears on MRI. It compared standard arthroscopic repair with repair augmented by bone marrow stimulation [1]. Every patient completed follow-up. The primary outcome was the IKDC subjective score at 12 months. It was about 83 in the augmented group against about 57 with standard repair, a gap of roughly 26 points. WOMAC, Lysholm, Tegner activity, pain and satisfaction scores all favoured augmentation as well, with no complications and no added operative time. Meniscal healing on 3 tesla MRI did not differ, with two of 25 menisci unhealed in each arm. The main limitation is size and balance. With only 50 patients, the augmented group received more sutures and had fewer horizontal tears, and either difference could contribute to the result. The control group's score is also low for a repaired meniscus. The authors call for larger trials with longer follow-up and structural assessment. The trial adds level one evidence that marrow stimulation may improve symptoms in the first year, without a measurable difference in healing on imaging.
The rotator cuff evidence this week is a meta-analysis from Tareen and colleagues, also in Knee Surgery Sports Traumatology Arthroscopy [2]. They pooled 15 randomized trials of platelet-rich plasma during arthroscopic rotator cuff repair, covering 1,214 patients, and grouped them by when the plasma was given: during surgery, after surgery only, or both. The primary outcome was retear on imaging at six months or later. Platelet-rich plasma cut the risk of retear by about half overall, with no heterogeneity across trials. The absolute reduction was about 12 percentage points, so roughly one retear was prevented for every eight patients treated. Intraoperative delivery carried the effect, and the benefit held at a year or more. Post-operative-only protocols did not show a statistically significant reduction, although too few trials used them to conclude that timing truly matters. Complications were not increased. The key limitation is that the structural gain did not translate consistently into better pooled functional scores, and both groups improved. This is the week's strongest evidence: randomized data showing a reproducible structural effect of intraoperative plasma, with the clinical payoff still unproven.
Moving to the hip, Boutera and colleagues in Acta Orthopaedica used the Norwegian Hip Fracture Register to study 98,607 patients aged 65 and over, treated between 2005 and 2023, comparing daytime, evening and nighttime surgery [3]. The mean age was 83. Just under half of patients were operated on in the day, about four in ten in the evening, and about one in ten at night. One-year reoperation was about 5 percent for daytime surgery and 6 percent at night, with no statistically significant difference after adjustment for age, health status, cognition, fracture and implant type, waiting time and operative duration. Intraoperative complications were identical, at 2.9 percent in each period. Nighttime surgery was linked with slightly lower 30-day mortality, under 8 percent against just under 10 percent in the day. The limitations are the observational design, possible confounding in which patients are operated on at night, and complications that surgeons reported themselves. Night patients also waited less for surgery. The study adds large-scale evidence that after-hours surgery in this health system was not associated with harm, which bears on the trade-off between operating promptly and waiting for a daytime list.
Now, four in brief.
Ward and colleagues, in Arthroscopy, add retrospective evidence on the same broad question of saving the meniscus [4]. At a single academic centre, 32 patients with isolated horizontal cleavage tears who had circumferential repair were propensity matched to patients who had partial meniscectomy, and followed for about five years. IKDC scores were 82 after repair against about 45 after meniscectomy, and Tegner activity was also higher. Failures, three after repair and five after meniscectomy, and return to sport did not differ significantly. The comparison is small, retrospective and matched only on basic demographics, so it is supportive but hypothesis-generating evidence for repair in this tear pattern.
Also in Arthroscopy, Duru and colleagues pooled 45 studies of 1,581 patients with massive irreparable rotator cuff tears treated with arthroscopic partial repair, with or without a human acellular dermal matrix [5]. Both approaches improved pain and function, and the ranges of improvement in shoulder scores were similar with and without the matrix. The matrix may be associated with lower retear rates, and complications were low with both techniques. This mirrors the platelet-rich plasma meta-analysis: a structural signal without a clear patient-reported advantage. Most included studies were non-randomized and the review is level four, so the comparison between techniques is indirect.
Turning to joint preservation, Maroyan and colleagues in Clinical Orthopedics and Related Research followed the first 142 patients, 171 hips, who had periacetabular osteotomy for dysplasia by one surgeon in the United States between 1991 and 1998 [6]. At a median of 27 years, 60 percent of the analysed hips remained preserved, survivorship free from hip replacement was 70 percent at 25 years, and median pain was low. Joint space of 2 millimetres or less, an intraoperative labral tear, and older age at surgery were linked to poor outcomes, with narrow joint space raising the hazard about sevenfold. Hips converted to replacement scored close to age norms. Almost a quarter of patients were lost to follow-up, and the series reflects one surgeon's early experience.
Registry data from Australia, reported by Vertullo and colleagues in Knee Surgery Sports Traumatology Arthroscopy, describe 2,563 knee osteotomies in mostly young men with osteoarthritis [7]. Reoperation occurred in under 3 percent of procedures, mainly for inadequate correction or delayed union. Conversion of valgus-producing tibial osteotomy to total knee replacement was about 2 percent at 8 years. In patients younger than 55 with osteoarthritis, medial unicompartmental replacement carried about a sixfold higher hazard of later total knee replacement than osteotomy. Follow-up is intermediate, thresholds for revising the two procedures may differ, and the comparison is observational and adjusted only for age and sex.
Three quick signals.
Back to hip fractures: in the Journal of Bone and Joint Surgery, Bishop and Goodnough argue that nonoperative care is a reasonable first option for selected valgus-impacted femoral neck fractures, in patients who are cognitively intact, independent, medically stable and able to protect weight-bearing, with delayed arthroplasty as salvage [8]. This is an expert opinion review, not new data.
In Knee Surgery Sports Traumatology Arthroscopy, Pecci and colleagues studied 199 competitive male pivoting athletes after ACL reconstruction [9]. Thigh muscle injury in the year after return affected about one in five athletes with patellar or quadriceps tendon grafts, against about one in eleven with hamstring grafts. It is retrospective, and no single muscle group difference survived adjustment.
Finally, in Spine, Tageldein and colleagues pooled 25 studies of isolated lumbar decompression and found 30-day deep vein thrombosis and pulmonary embolism each at about three events per 1,000 patients [10]. It is a counselling benchmark, but few studies reported prophylaxis, so it does not establish whether chemoprophylaxis helps.
Stepping back across this week's papers, the recurring pattern is a gap between imaging endpoints and what patients report. In the shoulder, biologic augmentation changed healing on imaging without a consistent functional difference, while in the knee a small trial showed the reverse, with symptom scores diverging and imaging unchanged. Much of the remaining evidence is registry or retrospective work, strong on scale and durability but limited in what it can attribute to the treatment itself.
If you only have time for one paper this week, make it the platelet-rich plasma meta-analysis from Tareen and colleagues [2]. It gives the clearest randomized answer so far on whether biologic augmentation changes cuff healing, and it reopens the question of whether that structural gain matters to patients.
That's your roundup for This Week in Orthopedics. The full transcript and references are available on the episode page. See you next week.
If this weekly briefing is useful, follow the show in your podcast app so new episodes arrive automatically. And think of one colleague, in any specialty, who never has time to keep up with the literature. Tell them about AudioScholar: a ten-minute weekly for every specialty, to listen to in any podcast app, or to read at audioscholar dot C C.
This is an automated summary generated by artificial intelligence, which can make mistakes. Use it to choose which papers to read in full.
Get Orthopedics every week
By email, Spotify, Apple or any podcast app.
Spot something worth flagging?